Prof Wise Young interviewed about clinical trials in China

US based Prof Wise Young has been instrumental in establishing the China Spinal Cord Injury Net, the world’s biggest clinical trial network for spinal cord therapies. Established in Hong Kong in 2005, it is about to expand into Europe, India and the US.

At about 20 centres in China, Hong Kong and Taiwan, stem cells are injected into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.

Read the full article in the West Australian

Prof Wise Young interviewed about clinical trials in China